CSN5 silencing reverses sorafenib resistance of human hepatocellular carcinoma HepG2 cells

Haibo Wang(Affiliated Hospital of Qingdao University), Zhonglian Li(Tianjin Nankai Hospital)
Molecular Medicine Reports
May 29, 2015
Cited by 18


Related Papers